The Dexcom Patient Assistance Program (“Program”) will be available to current U.S. customers who have lost their health insurance coverage as a result of the impact of the COVID-19 pandemic.* The Program will launch in the next several weeks and will be available during the COVID-19 pandemic in the United States.
For those existing U.S. customers who qualify for participation in Dexcom’s Program, Dexcom will offer:
Up to two shipments of 90-days of Dexcom continuous glucose monitoring (“CGM”) system supplies, with each shipment consisting of one transmitter and three boxes of three sensors
Reduce patient cost to $45 per 90-day supply shipment
Visit Dexcom.com/covid19-assistance for more information.